Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Chinese Medical Journal|July 24, 2019
A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphomaPeng Liu, Ying Han, Shi-Yu Jiang, et al.
Parasitology Research|May 22, 2017
Combined effects of Chinese medicine feed and ginger extract bath on co-infection of Ichthyophthirius multifiliis and Dactylogyrus ctenopharyngodonid in grass carpYao-Wu Fu, Bin Wang, Qi-Zhong Zhang, et al.
Medicine|February 13, 2016
GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeJing-Jing Wang, Mei Dong, Xiao-Hui He, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2005
[Quality of life of malignant patients after autologous stem cell transplantation]Bin Ai, Yuan-kai Shi, Xiao-hui He, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 8, 2010
[Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma]Yan Qin, Yuan-Kai Shi, Xiao-Hui He, et al.
International Journal of Hematology|November 22, 2013
High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysisLin Gui, Yuan-kai Shi, Xiao-hui He, et al.
Chinese Journal of Cancer|August 3, 2012
Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single centerXiao-Hui He, Bo Li, Shuang-Mei Zou, et al.
Chinese Medical Journal|September 15, 2015
Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with LymphomasPing Zhou, Peng Liu, Sheng-Yu Zhou, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 3, 2009
[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]Yan Qin, Yuan-Kai Shi, Xiao-Hui He, et al.
Future Oncology (London, England)|November 29, 2023
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocolJia-Ying Li, Shu-Nan Qi, Chen Hu, et al.
Pageof 6